Cachexia treatment
US10202449B2 · kind B2 · utility
5Cited by
0References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 11, 2017 |
| Grant date | Feb 12, 2019 |
| Priority date | — |
| Expiry date | Oct 11, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Administration of an antibody that specifically binds IL-1α is useful for treating cachexia and increasing the lifespan of a subject suffering from cachexia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.